About The Position

The Head of Medical Affairs, Emerging Therapies, is a leadership role responsible for advancing the scientific and clinical development of novel and pipeline therapies. The position provides strategic clinical innovation leadership across early- and mid-stage therapeutic programs, ensuring scientific rigor, clinical relevance, strategic alignment, and regulatory, market access, and commercial readiness. The role bridges clinical development, strategic planning, market adoption, and utilization by guiding and managing clinical strategy, engagement with clinical key opinion leaders and scientific opinion leaders, evidence generation, and internal and external program resources to support timely development and commercialization of innovative therapeutic solutions.

Responsibilities

  • Develop and lead the medical strategy for emerging therapies utilizing the 220KHz FUS platform.
  • Provide medical leadership and guidance for early-phase and translational programs.
  • Collaborate with R&D and strategic marketing to develop the current and future product portfolio, focusing on medical development pathways.
  • Monitor therapeutic trends, competitive landscapes, and scientific advances; collaborate with Strategic Marketing on strategic plans and competitive landscape analysis.
  • Collaborate with Clinical Affairs on the design, readiness, and execution of clinical trials, KOL selection, pre-clinical evidence as needed, and investigator-initiated research.
  • Collaborate with the CMO and business team to identify, recruit, and manage KOLs and scientific team members.
  • Align clinical trial timelines and endpoint definitions with commercial and go-to-market plans; support trial execution, including patient enrollment and journey, budget utilization, and data generation as needed.
  • Oversee publication strategy, data dissemination and generation, and podium presence.
  • Collaborate with Market Access to develop and execute global commercial readiness and reimbursement strategy.
  • Convene advisory boards to develop and validate clinical directions and decisions; coordinate with R&D, Regulatory Affairs, Clinical Affairs, and the CMO to ensure relevant teams are included in plans.
  • Partner with R&D, Clinical Affairs, Regulatory, the CMO office, Market Access, Commercial, and the Lotus team to drive timely and effective project execution.
  • Collaborate with the PMO to align medical strategy and timelines with development and lifecycle management plans.
  • Support go/no-go decisions and portfolio prioritization; present to management as needed to obtain approvals and buy-in.
  • Build and maintain relationships with KOLs, clinical and scientific investigators, and academic partners supporting development efforts.
  • Lead advisory boards, identify and develop clinical pathways, and drive consensus.
  • Manage and represent the organization at major congresses and symposia, including management of publication strategy and timelines.
  • Provide medical input for regulatory submissions and labeling; support risk management and safety communications.
  • Guide, mentor, and support development of a high-performing medical and clinical support team, fostering medical excellence, innovation, and cross-functional collaboration.
  • Support corporate strategic planning, pipeline development, global expansion, and lifecycle decisions; lead and manage the medical scientific chapter.
  • Plan and support launch readiness for first-in-class and best-in-class therapies.
  • Support post-marketing research, publications, and lifecycle optimization.

Benefits

  • Competitive perks and benefits are offered in each region.
  • Flexible work environment and a life-work balance philosophy.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service